ArticleCirculation2022

Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.

Ciaran N Kohli-Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.